Advertisement
Research Article

Use of Procalcitonin and C-Reactive Protein to Evaluate Vaccine Efficacy against Pneumonia

  • Shabir A Madhi mail,

    To whom correspondence should be addressed. E-mail: madhis@hivsa.com

    Affiliations: National Health Laboratory Service/University of the Witwatersrand/Medical Research Council Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa, Paediatric Infectious Diseases Research Unit, Wits Health Consortium, University of the Witwatersrand, Johannesburg, South Africa

    X
  • Jayvant R Heera,

    Affiliations: National Health Laboratory Service/University of the Witwatersrand/Medical Research Council Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa, Paediatric Infectious Diseases Research Unit, Wits Health Consortium, University of the Witwatersrand, Johannesburg, South Africa

    X
  • Locadiah Kuwanda,

    Affiliation: National Health Laboratory Service/University of the Witwatersrand/Medical Research Council Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa

    X
  • Keith P Klugman

    Affiliations: National Health Laboratory Service/University of the Witwatersrand/Medical Research Council Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa, Department of International Health, Rollins School of Public Health, and Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, Georgia, United States of America

    X
  • Published: February 22, 2005
  • DOI: 10.1371/journal.pmed.0020038

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Towards Better Evaluation of Pneumococcal Vaccines

Synopsis | published 22 Feb 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020053